肠道菌群与食管癌免疫治疗的研究进展.

Specific bacteria and dysbacteriosis in the gastrointestinal tract are closely related to the occurrence and development of tumors. At present, immunotherapy has made significant progress in the field of esophageal cancer treatment, bringing new hope to some esophageal cancer patients. However, the efficacy of immunotherapy for esophageal cancer is influenced by many factors, such as intestinal microflora. Therefore, regulating the level of microorganisms and enriching the microbiota in the intestine may achieve the goal of improving the efficacy of immunotherapy for esophageal cancer. The article reviews the role of gut microbiota in the occurrence and development of esophageal cancer, as well as its impact on the efficacy of tumor immunotherapy. [ABSTRACT FROM AUTHOR]